Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningCarboplatinTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsBlood Component RemovalAntineoplastic Combined Chemotherapy ProtocolsStem Cell TransplantationCyclophosphamideMultiple MyelomaMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalEtoposideThiotepaHematopoietic Stem CellsAntineoplastic Agents, AlkylatingRemission InductionRecurrenceIfosfamideCytophagocytosisCarmustineSalvage TherapyVincristineAmyloidosisDisease-Free SurvivalStem CellsCytarabineHematopoiesisHodgkin DiseaseCord Blood Stem Cell TransplantationTransplantation ChimeraNeoplasmsSurvival RateRetrospective StudiesTissue DonorsSurvival AnalysisWhole-Body IrradiationTime FactorsInfectionDoxorubicinLymphoma, T-CellPlatelet CountHistocompatibilityPOEMS SyndromeHistocompatibility TestingPrednisoneAntineoplastic AgentsImmunosuppressive AgentsLeukemia, Myeloid, AcuteDexamethasoneTransplantation, IsogeneicVidarabineFollow-Up StudiesBlood Cell CountRecombinant ProteinsLeukemiaBone Marrow PurgingProspective StudiesFeasibility StudiesLymphomaBlood CellsCytomegalovirus InfectionsGraft vs Leukemia EffectFatal OutcomeMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticHematologic DiseasesBlood Transfusion, AutologousLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionLeukocytes, MononuclearT-LymphocytesHistiocytosis, Non-Langerhans-CellPrognosisLivedo ReticularisBone MarrowOpportunistic InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaBreast NeoplasmsHLA AntigensCyclosporineBlood DonorsImmunosuppressionCell SeparationPilot Projects